1

B-cell maturation antigen targeting strategies in multiple myeloma treatment, advantages and disadvantages

jsgmwjykoim9
Abstract B cell maturation antigen (BCMA). a transmembrane glycoprotein member of the tumor necrosis factor receptor superfamily 17 (TNFRSF17). highly expressed on the plasma cells of Multiple myeloma (MM) patients. as well as the normal population. https://www.spidertattooz.com/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story